🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jason Willis

The University of Texas MD Anderson Cancer Center

ORCID: 0000-0001-8238-8552
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

3in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Supplementary Tables S1-S9 from The Transcriptomic Landscape of Mismatch Repair-Deficient Intestinal Stem Cells

INDIGO (University of Illinois at Chicago)(2023)10.1158/0008-5472.22427478.v1
Top 100%
0DataRank
Top 100%0 citations

Charles M. Bowen, Laura Reyes-Uribe, Wenhui Wu, Hiroyuki Katayama, Pedro Rocha +16 more

Papers

Driven by 23 papers — median percentile 0. Top paper: “Addition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal Adenocarcinoma (EXTEND): A Multicenter, Randomized Phase II Trial”.

Addition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal Adenocarcinoma (EXTEND): A Multicenter, Randomized Phase II Trial

Journal of Clinical Oncology(2024)10.1200/jco.24.00081
N/A
0.619DataRank · unranked
61 citations

Alexander D. Sherry, Bryan M. Fellman, Suyu Liu, Tharakeswara Bathala, Cara Haymaker +25 more

Phase 1/2 trial of encorafenib, cetuximab, and nivolumab in microsatellite stable BRAFV600E metastatic colorectal cancer

Cancer Cell(2025)10.1016/j.ccell.2025.08.002
N/A
0.477DataRank · unranked
23 citations

Christine M. Parseghian, Vahid Bahrambeigi, Nourhan Abdelfattah, Lianchun Xiao, Anjali Agrawal +28 more

Antibiotic Exposure Does Not Impact Immune Checkpoint Blockade Response in MSI-H/dMMR Metastatic Colorectal Cancer: A Single-Center Experience

The Oncologist(2022)10.1093/oncolo/oyac162
N/A
0.464DataRank · unranked
21 citations

Jane E. Rogers, Hyunsoo Hwang, Wei Qiao, Lianchun Xiao, Arvind Dasari +11 more

Phase I trial of single-photon emission computed tomography–guided liver-directed radiotherapy for patients with low functional liver volume

JNCI Cancer Spectrum(2024)10.1093/jncics/pkae037
N/A
0.340DataRank · unranked
6 citations

Franklin C. Wong, Beth Chasen, William D. Erwin, Prajnan Das, Emma B. Holliday +27 more

Phase I study of hydroxychloroquine plus binimetinib in patients with metastatic pancreatic cancer (the HOPE trial).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.tps634
N/A
0.269DataRank · unranked
5 citations

J. Jack Lee, Brandon G. Smaglo, Dan Zhao, Michael Sangmin Lee, Robert A. Wolff +5 more

Inducing Hypermutability to Promote Anti–PD-1 Therapy Response

Cancer Discovery(2022)10.1158/2159-8290.cd-22-0492
N/A
0.245DataRank · unranked
3 citations

Michael J. Overman, Jason Willis

Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0340
N/A
0DataRank · unranked
15 citations

Jane V. Thomas, Kaysia Ludford, Jason Willis, Victoria Serpas Higbie, Kanwal Raghav +15 more

Dose-escalated pancreas radiotherapy for unresected pancreatic adenocarcinoma: Patterns of care and survival in the United States.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.676
N/A
0DataRank · unranked
1 citations

Brian De, Marcus A. Florez, Hop Sanderson Tran Cao, Sunyoung S. Lee, Jason Willis +10 more

ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-2404
N/A
0DataRank · unranked
52 citations

Jumanah Alshenaifi, Jason Roszik, Ganiraju C. Manyam, Shailesh Advani, Riham Katkhuda +13 more

Data from ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer

(2023)10.1158/1078-0432.c.6530583
N/A
0DataRank · unranked
0 citations

Jumanah Alshenaifi, Jason Roszik, Ganiraju C. Manyam, Shailesh Advani, Riham Katkhuda +13 more

Data from ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer

(2023)10.1158/1078-0432.c.6530583.v1
N/A
0DataRank · unranked
0 citations

Jumanah Alshenaifi, Jason Roszik, Ganiraju C. Manyam, Shailesh Advani, Riham Katkhuda +13 more

Supplementary Tables S1-S9 from The Transcriptomic Landscape of Mismatch Repair-Deficient Intestinal Stem Cells

INDIGO (University of Illinois at Chicago)(2023)10.1158/0008-5472.22427478.v1
Top 100%
0DataRank
Top 100%0 citations

Charles M. Bowen, Laura Reyes-Uribe, Wenhui Wu, Hiroyuki Katayama, Pedro Rocha +16 more

Data from Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination

(2023)10.1158/2767-9764.c.6975005.v1
Top 100%
0DataRank
Top 100%0 citations

Jane V. Thomas, Kaysia Ludford, Jason Willis, Victoria Serpas Higbie, Kanwal Raghav +15 more

Escalated‐dose radiotherapy for unresected locally advanced pancreatic cancer: Patterns of care and survival in the United States

Cancer Medicine(2024)10.1002/cam4.7434
N/A
0DataRank · unranked
6 citations

Brian De, Hop S. Tran Cao, Suyu Liu, Marcus A. Florez, Ramez Kouzy +17 more

Mutational and co-mutational landscape of early onset colorectal cancer

Biomarkers(2025)10.1080/1354750x.2024.2447089
N/A
0DataRank · unranked
24 citations

Guglielmo Vetere, Giulia Maddalena, Mahmoud Yousef, Michael G. White, John Paul Shen +14 more

Tumoral and circulating genomic landscape inform survival differences in colorectal carcinomatosis

Translational Oncology(2025)10.1016/j.tranon.2025.102379
N/A
0DataRank · unranked
0 citations

Reed I. Ayabe, Mohammad A. Zeineddine, Fadl A. Zeineddine, Abdelrahman Yousef, Mahmoud Yousef +12 more

1336 Final Ph1b/2 results for nous-209 monotherapy in lynch syndrome carriers: annual revaccination boosts T cell immunity informing future cancer interception strategies

(2025)10.1136/jitc-2025-sitc2025.1336
N/A
0DataRank · unranked
0 citations

Jason Willis, Michael J. Hall, Marcia Cruz‐Correa, Gregory Idos, Selvi Thirumurthi +19 more

Data from The Transcriptomic Landscape of Mismatch Repair-Deficient Intestinal Stem Cells

(2023)10.1158/0008-5472.c.6512688.v1
N/A
0DataRank · unranked
0 citations

Charles M. Bowen, Laura Reyes-Uribe, Wenhui Wu, Hiroyuki Katayama, Pedro Rocha +16 more

The Transcriptomic Landscape of Mismatch Repair-Deficient Intestinal Stem Cells

Cancer Research(2021)10.1158/0008-5472.can-20-2896
N/A
0DataRank · unranked
10 citations

Charles M. Bowen, Laura Reyes-Uribe, Wenhui Wu, Hiroyuki Katayama, Pedro Rocha +16 more

Sensei: How Many Samples to Tell Evolution in Single-Cell Studies?

Research Square(2021)10.21203/rs.3.rs-639869/v1
N/A
0DataRank · unranked
1 citations

Jason Willis, Jinzhuang Dou, Vakul Mohanty, Yuefan Huang, Eduardo Vilar +2 more

Sensei: how many samples to tell a change in cell type abundance?

BMC Bioinformatics(2022)10.1186/s12859-021-04526-5
N/A
0DataRank · unranked
8 citations

Jason Willis, Jinzhuang Dou, Vakul Mohanty, Yuefan Huang, Eduardo Vilar +2 more

Phase 2 study of anti-EGFR rechallenge therapy with panitumumab with or without trametinib in advanced colorectal cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3520
N/A
0DataRank · unranked
9 citations

Eduardo Vilar Sanchez, Ryan Sun, Madhulika Eluri, Van K. Morris, Benny Johnson +11 more

RAS co-mutation and early onset disease represent an aggressive phenotype of atypical (non-V600) BRAF mutant metastatic colorectal cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3592
N/A
0DataRank · unranked
0 citations

Dongyun Yang, Hiba I. Dada, Van K. Morris, Xuemei Wang, Arvind Dasari +14 more